In this week’s episode of Tuning In to the C-Suite podcast, MHE's Senior Editor Peter Wehrwein and Associate Editor Briana Contreras spoke with CEO of Syntellis Performance Solutions, Kermit Randa. In the discussion they talked about a recently released survey by Syntellis called the 2021 Healthcare Financial Trends Survey report, which highlights how finance leaders pivoted in 2020 and the way they will continue to evolve in 2021.
Findings from an analysis of IQVIA claims data show a prevalence rate that is five times lower than previous reports. Some of the discrepancy could be chalked up to the difference between using claims data instead of self-reporting by survey respondents.
Epic Research finds over half of children with type 1 diabetes miss autoantibody testing, risking misdiagnosis and limiting early treatment options like Tzield.
Higher MRI-measured liver disease activity was linked to lower quality of life and more anxiety and activity problems in 802 adults with suspected MASLD/MASH in Europe.
MassHealth's Katelyn Meyer, Pharm.D., says mandatory coverage, young patients and an unpredictable FDA make planning for new specialty drugs a challenge.
As pulmonary fibrosis treatment options grow, Rachael Prusi of Prime Therapeutics says health plans should lean on guidelines and strong case management.
